Latest Biotech (general) News
Drug Prices: How Biotech Companies Are Bracing For Potential Reforms
Political rhetoric surrounding drug prices could slam biotech companies like Celgene and Incyte as the election season ramps up, an analyst said Monday.
Updated: 07/24/2019 03:00A
Harvard launches MS/MBA biotech program
The Harvard University Graduate School of Arts and Sciences in Cambridge, Mass., and Harvard Business School in Boston recently unveiled a new joint ...
Updated: 07/23/2019 02:24P
3 “Perfect 10” Biotech Stocks to Buy
When looking for compelling stocks with significant long-term growth potential, investors will often turn to biotechs. A biotech is any company that uses ...
Updated: 07/23/2019 03:03A
Biotech Company Detraxi Is Developing a Solution to Eliminate Global Blood Shortages
Blood supplies are essential for saving lives, but China's demand for blood exceeds supply. Detraxi, a biotechnology company, is working on a regenerative ...
Updated: 07/21/2019 08:04P
Biotech enters an era of 'platform' dominance
So-called platform companies raised $659 million in Series A dollars the first half of 2019, surpassing the amount raised by oncology companies.
Updated: 07/19/2019 12:14P
4 Best-Performing Biotech Mutual Funds in 2019 So Far
After stumbling into the bear market territory in the second half of last year, the U.S. biotechnology sector recovered in the first six months of this year.
Updated: 07/18/2019 10:07A
Biotech building facility to make genome-edited, off-the-shelf CAR-T therapies
Precision BioSciences is building a facility to produce allogeneic CAR-T cell therapies with a capacity to generate up to 10,000 doses of CAR-T cell therapies ...
Updated: 07/18/2019 09:41A
Biotech incubator acquires U of C startup
Paragon Biosciences' newest portfolio company aims to help radiologists accurately diagnose breast cancer.
Updated: 07/17/2019 06:00A
China Has Big Presence in Top 10 Biotech IPOs this Year
A list of the top 10 biotech IPOs from January to the end of June this year shows significant involvement in the Hong Stock exchange, with five companies based ...
Updated: 07/17/2019 12:09A
Doctor Who Sold $12 Billion Drug Firm Eyes Biotech Property
A deal-making cancer doctor who sold his pharmaceutical company for almost $12 billion is launching a real estate venture to bolster the growth of the ...
Updated: 07/16/2019 01:23P